Clinical Trials Directory

Trials / Terminated

TerminatedNCT02050737

Plasma Biomarkers C-RAC, ICORG 12-27, V1

Identification of Plasma Biomarkers in Early Detection of Colorectal Adenocarcinoma Recurrence (C-RAC Plasma Biomarker Study)

Status
Terminated
Phase
Study type
Observational
Enrollment
109 (actual)
Sponsor
Cancer Trials Ireland · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is an exploratory, translational, non-interventional and multi-centre clinical study.

Detailed description

Cohort A will consist of 100 CRAC patients with stage II/III resectable disease due for adjuvant chemotherapy. Cohort B will consist of 30 patients with stage II resectable disease for observation only. Both cohorts will have a follow up period of up to 2 years, post chemotherapy for cohort A and post resection for cohort B.

Conditions

Timeline

Start date
2013-10-01
Primary completion
2021-07-13
Completion
2021-07-13
First posted
2014-01-31
Last updated
2025-07-08

Locations

14 sites across 1 country: Ireland

Source: ClinicalTrials.gov record NCT02050737. Inclusion in this directory is not an endorsement.

Plasma Biomarkers C-RAC, ICORG 12-27, V1 (NCT02050737) · Clinical Trials Directory